Latest AI and machine learning research in allergy for healthcare professionals.
RATIONALE AND OBJECTIVES: The non-invasive biomarkers for predicting progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC) treated with immunotherapy and molecular targeted therapy combined with transarterial chemoembolization (IMT-MTT-TACE) are urgently needed to identify individuals who are likely to benefit from this treatment regimen. This study aims to develop a non-...
Exosomes, nano-sized extracellular vesicles secreted by almost all cell types, have emerged as biologically compatible vehicles for targeted drug delivery, gene therapy, and molecular diagnostics. Their innate ability to traverse biological barriers and deliver diverse cargoes with minimal immunogenicity has catalyzed intense interest in their therapeutic exploitation. However, the intrinsic heter...
Chimeric antigen receptor (CAR)-T cell immunotherapy shows significant success in hematologic malignancies. However, it faces critical challenges in s...
BACKGROUND: Current relevance of positive patch-test reactions guides management in allergic contact dermatitis (ACD), yet its clinical predictors and...
Esophageal squamous cell carcinoma (ESCC) lacks a standardized classification system, resulting in inconsistent clinical management and a suboptimal p...
The advent of immunotherapy and targeted therapy has revolutionized oncology treatment in recent years, marking a transformative shift toward precisio...
Lipid nanoparticle (LNP)-mRNA technology has profoundly transformed the biomedical landscape, establishing itself as a highly versatile and powerful p...
Monoclonal gammopathies span a continuum from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to overt...
The primary approach to the treatment of seasonal allergic diseases involves minimizing exposure to allergens and initiating early personalized therap...
Immune checkpoint inhibitors and anti-angiogenic targeted therapies have improved outcomes in hepatocellular carcinoma (HCC), but responses remain het...
BACKGROUND: Current atopic dermatitis (AD) therapy selection does not account for molecular drivers of disease, contributing to inadequate disease con...
Immune checkpoint blockade, particularly programmed cell death protein 1 inhibition, has redefined the management of classic Hodgkin lymphoma (cHL), a...
Chimeric antigen receptor natural killer (CAR-NK) cell therapy is an emerging cancer treatment offering advantages over CAR-T therapy, including reduc...
BACKGROUND: Endocrine-disrupting chemicals (EDCs) are common environmental pollutants that affect human health. These chemicals have been linked to th...
BACKGROUND: The response of resectable non-small cell lung cancer (NSCLC) to neoadjuvant immunotherapy is heterogeneous. Machine learning can integrat...
OBJECTIVE: Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates ...
Recent advances in artificial intelligence (AI) and multimodal data collection are revolutionizing dermatology. Generative AI and machine-learning app...
Tyrosine kinase inhibitor (TKI) combined with immunotherapy regimens are now widely used for treating advanced hepatocellular carcinoma (HCC), but the...
PURPOSE OF REVIEW: The advent of high-throughput data generation and artificial intelligence has transformed allergy research. Open-access database (O...
Artificial intelligence systems are beginning to function as "co-scientists" in cancer research, generating drug candidates, prioritizing immunotherap...